Pharmaceutical Technology-12-02-2004

This article provides guidance for developing dissolution testing for poorly soluble compounds. It is the second of a series of articles based on material from a 2003 PhRMA workshop about acceptable analytical practices.

Microspheres of Eudragit RL were developed for colonic delivery of albendazole. The effects of polymer concentration, stirring rate, and concentration of emulsifier on particle size and drug loading were studied. A comparative in vitro drug release study of the optimized formulation was carried out.

Articles
Pharmaceutical Technology

December 02, 2004

Pharmaceutical Science & Technology Innovations

Researchers are improving photodynamic therapies with new photosensitizers and light sources for deeper tissue penetration, more site-specific treatments, and reduced side effects.

Articles
Pharmaceutical Technology

December 02, 2004

Blockbuster drugs turn out to be risky business, while contamination problems shut down flu vaccine production.

Articles
Pharmaceutical Technology

December 02, 2004

Pharmaceutical Science & Technology News

Articles
Pharmaceutical Technology

December 02, 2004

The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.

Articles
Pharmaceutical Technology

December 02, 2004

More than 1500 pharmaceutical industry employees worldwide provide a personal view into the issues that matter most in the workforce, including salary and benefits, skills and education, and perspectives on the current job market.

Articles
Pharmaceutical Technology

December 02, 2004

On the other hand, if we don't keep up the pressure on counterfeiting in the US, we may share the plight of the developing world, where nearly 25% of all drugs sold are fakes.